Search

everythinglearnresearchcommunity

for

Search:↓

The Rotterdam Study aims to understand various diseases in older adults.

Androgens can both increase and decrease hair growth in different parts of the body.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

The document concludes that more research is needed to understand how to treat muscle pain with drugs.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Hair growth is influenced by hormones and goes through different phases; androgens can both promote and inhibit hair growth depending on the body area.

The meeting discussed medical findings, including benefits of certain treatments for cancer and heart conditions, and highlighted issues like poor adherence to preventive measures and skill gaps among interns.

Ayurveda's descriptions of genetic disorders align with modern genetic understanding.

PCOS often leads to sleep problems, especially obstructive sleep apnea, affecting overall health.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

The symposium concluded that hair growth involves complex processes, including the hair follicle life cycle, the role of the dermal papilla, hair strength, pigmentation, and the impact of diseases and treatments like minoxidil on hair and skin.

The meeting covered new findings in children's skin conditions and treatments, including the benefits of super absorbent polymer diapers.

Old drugs are often used for new, different medical purposes in endocrine pharmacology.

Ring Chromosome 11 may be linked to conditions like early puberty, excessive hair growth, hair loss, and type 2 diabetes.

The conclusion is that obesity should be managed with a slow, balanced approach to diet and exercise, with medication and surgery as additional options, and education and access to care are important.

Melatonin and mitotane treatment led to hair re-growth in 62% of dogs with Alopecia X, but this was not always linked to normal hormone levels.

Hormones, especially androgens, play a big role in acne, but most acne sufferers don't have a hormone disorder. Hormonal treatments, including birth control pills, can be very effective for women whose acne doesn't improve with regular treatments.

Genetic screening is crucial for accurately diagnosing APS-1 due to its varied symptoms.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Birth control pills with low-dose estrogen and antiandrogenic progestins can effectively treat acne.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Essential oils may improve dogs' health and melatonin can help with their sleep and anxiety, but both should be used carefully.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.